Following the cancer trail

Aggressive melanoma cells leave a molecular trail in the extracellular matrix enabling less aggressive cells to become more aggressive.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Cancer cells can metastasize and invade other organs because they produce enzymes that destroy extracellular matrices. Until now the extracellular matrix was considered passive to the cancer attack. But in September 1 Cancer Research, Richard Seftor and colleagues from The University of Iowa show that highly aggressive melanoma cells leave a persistent molecular track in the extracellular matrix which can make less aggressive cancer cells much more aggressive.

Using microarray gene chip analyses Seftor et al. found that aggressive melanoma cells express increased amounts of metalloproteinases MMP-2, MT1-MMP and Ln-5γ2 chain, which they leave behind in the extracellular matrix. When poorly aggressive melanoma cells were seeded on matrices preconditioned by the aggressive cells they started forming tubular networks along the Ln-5γ2 chain-enriched tracks deposited by the aggressive cells (Cancer Res 2001, 61:6322-6327).

"The implications of this study suggest that the matrix of tumors might serve as an excellent target to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Tudor Toma

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo